{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T01:54:48Z","timestamp":1775267688178,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Aims<\/jats:title>\n            <jats:p>The purpose of this study was to determine if any relationship exists between expression of COX2 and iNOS markers and urinary <jats:italic>schistosomiasis<\/jats:italic> in bladder cancers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methodology<\/jats:title>\n            <jats:p>Immunohistochemical expression of COX2 and iNOS was assessed in formalin fixed paraffin wax processed tissues obtained from 155 patients with bladder cancers (87 SCC and 68 TCC) and 39 patients with benign bladder cystitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The overall immune-expressions of COX2 and iNOS were 71.6% and 57.2% respectively, of the 194 bladder lesions. A significant Positive association between COX2 or iNOS expression with bladder lesions (SCC, TCC and cystitis) was found (p.value\u2009=\u20090.000). COX2 and iNOS were co-expressed among 73(83.9%) of SCC, 15(22.1%) of TCC and 11(28.2%) of the cystitis group. The relationship between COX2 and iNOS immunostaining and Schistosomal ova positivity was statistically determined by P values 0.0565 and 0.1223 for Cox2 and iNOS, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>There are high rates of positive expression of COX2 and iNOS among Sudanese patients with Schistosomal-related bladder lesions. There might be strong association between high rates of bladder cancers and urinary Schistosomiasis in the Sudan since, the great majority of lesions were positive for COX2.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1750-9378-8-9","type":"journal-article","created":{"date-parts":[[2013,2,15]],"date-time":"2013-02-15T13:14:40Z","timestamp":1360934080000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Immunohistochemical expression of COX2 and iNOS in bladder cancer and its association with urinary schistosomiasis among Sudanese patients"],"prefix":"10.1186","volume":"8","author":[{"given":"Hassan Elsiddig","family":"Hassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Abdel Badie","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amel Omer","family":"Bakhiet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussain Gadelkarim","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,15]]},"reference":[{"key":"425_CR1","volume-title":"Cancer incidence, mortality and prevalence worldwide (2002), version 1.0. IARC Cancer Base No. 5","author":"J Ferlay","year":"2004","unstructured":"Ferlay J, Bray F, Pisan P, Parkin DM, Globocan: Cancer incidence, mortality and prevalence worldwide (2002), version 1.0. IARC Cancer Base No. 5. 2004, Lyoo: IARC press"},{"key":"425_CR2","first-page":"3899","volume":"15","author":"CF Heyns","year":"2008","unstructured":"Heyns CF, Van der Merwe A: Bladder cancer in Africa. Can J Urol. 2008, 15: 3899-3908.","journal-title":"Can J Urol"},{"key":"425_CR3","first-page":"158","volume":"19","author":"I Gouda","year":"2007","unstructured":"Gouda I, Mokhtar N, Bilal D, El-Bolkainy T, El-Bolkainy NM: Bilharziasis and bladder cancer: a time trend analysis of 9843 patients. J Egypt Natl Canc Inst. 2007, 19: 158-162.","journal-title":"J Egypt Natl Canc Inst"},{"key":"425_CR4","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s10552-007-9104-7","volume":"19","author":"AS Felix","year":"2008","unstructured":"Felix AS, Soliman AS, Khaled H, Zaghloul MS, Banerjee M, El-Baradie M: The changing patterns of bladder cancer in Egypt over the past 26 years. Cancer Causes Control. 2008, 19: 421-429. 10.1007\/s10552-007-9104-7.","journal-title":"Cancer Causes Control"},{"key":"425_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/00001813-200202000-00003","volume":"13","author":"XC Yu","year":"2002","unstructured":"Yu XC: Cyclooxygenase \u22122 Inhibitors in Cancer treatment and prevention: a recent development. Anti Cancer Drug. 2002, 13: 127-137. 10.1097\/00001813-200202000-00003.","journal-title":"Anti Cancer Drug"},{"key":"425_CR6","first-page":"2424","volume":"6","author":"T Shirahama","year":"2000","unstructured":"Shirahama T: Molecular oncology, Marker, Clinical Correlates: Cyclooxygenase \u22122 Expression is up \u2013 regulated in transitional cell carcinoma and its Preneoplastic Lesions in the human urinary bladder. Clin Cancer Res. 2000, 6: 2424-2430.","journal-title":"Clin Cancer Res"},{"key":"425_CR7","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1073\/pnas.94.7.3336","volume":"94","author":"M TsuJii","year":"1997","unstructured":"TsuJii M, Kawano S, Dubios RW: Cyclooxygenase \u22122 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA. 1997, 94: 3336-3340. 10.1073\/pnas.94.7.3336.","journal-title":"Proc Natl Acad Sci USA"},{"key":"425_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.colsurfb.2004.06.006","volume":"37","author":"GO Li","year":"2004","unstructured":"Li GO, Yang T, Li L, Yan J, Zeng Y, Yu J: Cyclooxygenase-2 Parallels invasive depth and increased MVD in transitional cell carcinoma. Cell surf Biointer. 2004, 37: 9-15. 10.1016\/j.colsurfb.2004.06.006.","journal-title":"Cell surf Biointer"},{"key":"425_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11255-004-4699-z","volume":"37","author":"P Wadhwa","year":"2005","unstructured":"Wadhwa P, Goswami AK, Joshi K, Sharma SK: Cyclooxygenase-2 expression increases with the stage and grade in transitional cell carcinoma of the urinary bladder. Int Urol Nephrol. 2005, 37: 47-53. 10.1007\/s11255-004-4699-z.","journal-title":"Int Urol Nephrol"},{"key":"425_CR10","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/S0006-291X(89)80037-3","volume":"165","author":"M Palacios","year":"1989","unstructured":"Palacios M, Knowles RG, Palmer RM, Moncada S: Nitric oxide from L-arginine stimulates the soluble guanylate cyclase in adrenal glands. Biochem Biophy Res Commun. 1989, 165: 802-809. 10.1016\/S0006-291X(89)80037-3.","journal-title":"Biochem Biophy Res Commun"},{"key":"425_CR11","doi-asserted-by":"crossref","first-page":"13725","DOI":"10.1016\/S0021-9258(17)36703-0","volume":"269","author":"C Nathan","year":"1994","unstructured":"Nathan C, Xie QW: Regulation of biosynthesis of nitric oxide. J Biol Chem. 1994, 269: 13725-13728.","journal-title":"J Biol Chem"},{"key":"425_CR12","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1177\/014107689608901204","volume":"89","author":"K Bhagat","year":"1996","unstructured":"Bhagat K, Vallance P: Nitric oxide 9 years on. J R Soc Med. 1996, 89: 667-673.","journal-title":"J R Soc Med"},{"key":"425_CR13","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s00240-003-0302-9","volume":"31","author":"Z Lin","year":"2003","unstructured":"Lin Z, Chen S, Ye C, Zhu S: Nitric oxide synthase expression in human bladder cancer and its relation to angiogenesis. Urol Res. 2003, 31: 232-235. 10.1007\/s00240-003-0302-9.","journal-title":"Urol Res"},{"key":"425_CR14","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/S0022-5347(01)61985-2","volume":"161","author":"HS Swana","year":"1999","unstructured":"Swana HS, Smith SD, Perrotta PL, Saito N, Wheeler MA, Weiss RM: Inducible nitric oxide synthase with transitional cell carcinoma of the bladder. J Urol. 1999, 161: 630-634. 10.1016\/S0022-5347(01)61985-2.","journal-title":"J Urol"},{"key":"425_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3402\/ljm.v7i0.14694","volume":"7","author":"K El Gehani","year":"2012","unstructured":"El Gehani K, Al-Kikhia L, Emaetig F, Syrj\u00e4nen K, Al-Fituri O, Elzagheid A: Over-expression of HER-2 is associated with the stage in carcinomas of the urinary bladder. Libyan J Med. 2012, 7: 10-","journal-title":"Libyan J Med"},{"key":"425_CR16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/(SICI)1098-2388(199709\/10)13:5<291::AID-SSU2>3.0.CO;2-8","volume":"13","author":"SL Johansson","year":"1997","unstructured":"Johansson SL, Cohen SM: Epidemiology and etiology of bladder cancer. Semin Surg Onco. 1997, 13: 291-298. 10.1002\/(SICI)1098-2388(199709\/10)13:5<291::AID-SSU2>3.0.CO;2-8.","journal-title":"Semin Surg Onco"},{"key":"425_CR17","first-page":"219","volume":"78","author":"MO Malik","year":"1975","unstructured":"Malik MO, Veress B, Daoud EH: Pattern of bladder cancer in the Sudan and its relation to schistosomiasis: a study of 255 vesical carcinomas. J Trop Med Hyg. 1975, 78: 219-223.","journal-title":"J Trop Med Hyg"},{"key":"425_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1756-9966-28-27","volume":"28","author":"AS Abdulamir","year":"2009","unstructured":"Abdulamir AS, Hafidh R, Kadhim HS, Abubakar F: Tumor markers of bladder cancer: the schistosomal bladder tumors versus non-schistosomal bladder tumors. Clin Cancer Res. 2009, 28: 27-10.1186\/1756-9966-28-27.","journal-title":"Clin Cancer Res"},{"key":"425_CR19","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.1200\/JCO.2007.14.2364","volume":"25","author":"L Harris","year":"2007","unstructured":"Harris L, Fritsche H, Mennel R: American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol. 2007, 25: 5287-5312. 10.1200\/JCO.2007.14.2364.","journal-title":"J Clin Oncol"},{"key":"425_CR20","first-page":"558","volume":"7","author":"T Shirahama","year":"2001","unstructured":"Shirahama T, Sakakura C: Overexpression of Cyclooxygenase-2 in squamous cell carcinoma of the urinary bladder. Clinical Cancer Res. 2001, 7: 558-561.","journal-title":"Clinical Cancer Res"},{"key":"425_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1600-0463.2008.00014.x","volume":"117","author":"M Moussa","year":"2009","unstructured":"Moussa M, Omran Z, Nosseir M, Lotfy A, Swellam T: Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma. APMIS. 2009, 117: 45-52. 10.1111\/j.1600-0463.2008.00014.x.","journal-title":"APMIS"},{"key":"425_CR22","first-page":"234","volume":"10","author":"OA Hammam","year":"2008","unstructured":"Hammam OA, Ahmed AA, Mamdouh SR, Ahmed MAH: Possible Role of Cyclooxygenase-2 in Schistosomal and Non-Schistosomal-Associated Bladder Cancer. Medscape J Med. 2008, 10: 234-237.","journal-title":"Medscape J Med"},{"issue":"1","key":"425_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1464-410X.2010.09854.x","volume":"108","author":"R Youssef","year":"2011","unstructured":"Youssef R, Kapur P, Kabbani W, Shariat SF, Mosbah A, Abol-Enein H, Ghoniem M, Lotan Y: Bilharzial versus non-bilharzial related bladder cancer: pathological characteristics and value of cyclooxygenase-2 expression. BJU Int. 2011, 108 (1): 31-37. 10.1111\/j.1464-410X.2010.09854.x.","journal-title":"BJU Int"},{"key":"425_CR24","first-page":"109","volume":"43","author":"S Moncada","year":"1991","unstructured":"Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991, 43: 109-142.","journal-title":"Pharmacol Rev"},{"key":"425_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev.bi.63.070194.001135","volume":"63","author":"DS Bredt","year":"1994","unstructured":"Bredt DS, Snyder SH: Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem. 1994, 63: 175-195. 10.1146\/annurev.bi.63.070194.001135.","journal-title":"Annu Rev Biochem"},{"key":"425_CR26","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1093\/carcin\/15.10.2081","volume":"15","author":"VJS Chhatwal","year":"1994","unstructured":"Chhatwal VJS, Ngoi SS, Chan STF: Aberrant expression of nitric oxide synthase in human polyps, neoplastic colonic mucosa and surrounding peri tumoral normal mucosa. Carcinogenesis. 1994, 15: 2081-2085. 10.1093\/carcin\/15.10.2081.","journal-title":"Carcinogenesis"},{"key":"425_CR27","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/bjc.1994.409","volume":"70","author":"DC Jenkins","year":"1994","unstructured":"Jenkins DC, Charles IG, Baylis SA: Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. Br J Cancer. 1994, 70: 847-849. 10.1038\/bjc.1994.409.","journal-title":"Br J Cancer"},{"issue":"3","key":"425_CR28","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/ijc.23547","volume":"123","author":"EI Salim","year":"2008","unstructured":"Salim EI, Morimura K, Menesi A, El-Lity M, Fukushima S, Wanibuchi H: Elevated oxidative stress and DNA damage and repair levels in urinary bladder carcinomas associated with schistosomiasis. Int J Cancer. 2008, 123 (3): 601-608. 10.1002\/ijc.23547.","journal-title":"Int J Cancer"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-9378-8-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T22:38:21Z","timestamp":1630535901000},"score":1,"resource":{"primary":{"URL":"https:\/\/infectagentscancer.biomedcentral.com\/articles\/10.1186\/1750-9378-8-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,15]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["425"],"URL":"https:\/\/doi.org\/10.1186\/1750-9378-8-9","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,15]]},"assertion":[{"value":"3 June 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"9"}}